These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36206307)

  • 1. Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques.
    Chua BY; Sekiya T; Koutsakos M; Nomura N; Rowntree LC; Nguyen THO; McQuilten HA; Ohno M; Ohara Y; Nishimura T; Endo M; Itoh Y; Habel JR; Selva KJ; Wheatley AK; Wines BD; Hogarth PM; Kent SJ; Chung AW; Jackson DC; Brown LE; Shingai M; Kedzierska K; Kida H
    PLoS Pathog; 2022 Oct; 18(10):e1010891. PubMed ID: 36206307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
    Shingai M; Nomura N; Sekiya T; Ohno M; Fujikura D; Handabile C; Omori R; Ohara Y; Nishimura T; Endo M; Kimachi K; Mitsumata R; Ikeda T; Kitayama H; Hatanaka H; Sobue T; Muro F; Suzuki S; Thanh Nguyen C; Ishigaki H; Nakayama M; Mori Y; Itoh Y; Koutsakos M; Chua BY; Kedzierska K; Brown LE; Jackson DC; Ogasawara K; Kino Y; Kida H
    Vaccine; 2021 Jun; 39(29):3940-3951. PubMed ID: 34090697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated Whole Virus Particle Influenza Vaccine Induces Anti-Neuraminidase Antibodies That May Contribute to Cross-Protection against Heterologous Virus Infection.
    Handabile C; Sekiya T; Nomura N; Ohno M; Kawakita T; Shingai M; Kida H
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaques.
    Ohno M; Sagata M; Sekiya T; Nomura N; Shingai M; Endo M; Kimachi K; Suzuki S; Thanh Nguyen C; Nakayama M; Ishigaki H; Ogasawara K; Itoh Y; Kino Y; Kida H
    Vaccine; 2023 Jan; 41(3):787-794. PubMed ID: 36526501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivated whole influenza virus particle vaccines induce neutralizing antibodies with an increase in immunoglobulin gene subclones of B-lymphocytes in cynomolgus macaques.
    Shiohara M; Suzuki S; Shichinohe S; Ishigaki H; Nakayama M; Nomura N; Shingai M; Sekiya T; Ohno M; Iida S; Kawai N; Kawahara M; Yamagishi J; Ito K; Mitsumata R; Ikeda T; Motokawa K; Sobue T; Kida H; Ogasawara K; Itoh Y
    Vaccine; 2022 Jun; 40(30):4026-4037. PubMed ID: 35641357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemagglutinin-specific CD4
    Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
    Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.
    Sekiya T; Mifsud EJ; Ohno M; Nomura N; Sasada M; Fujikura D; Daito T; Shingai M; Ohara Y; Nishimura T; Endo M; Mitsumata R; Ikeda T; Hatanaka H; Kitayama H; Motokawa K; Sobue T; Suzuki S; Itoh Y; Brown LE; Ogasawara K; Kino Y; Kida H
    Vaccine; 2019 Apr; 37(15):2158-2166. PubMed ID: 30857932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory immune responses against pandemic (H1N1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying Mafa-A1*052:02.
    Arikata M; Itoh Y; Okamatsu M; Maeda T; Shiina T; Tanaka K; Suzuki S; Nakayama M; Sakoda Y; Ishigaki H; Takada A; Ishida H; Soda K; Pham VL; Tsuchiya H; Nakamura S; Torii R; Shimizu T; Inoko H; Ohkubo I; Kida H; Ogasawara K
    PLoS One; 2012; 7(5):e37220. PubMed ID: 22623997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains.
    Wang J; Li D; Perry S; Hilchey SP; Wiltse A; Treanor JJ; Sangster MY; Zand MS
    mBio; 2021 Aug; 12(4):e0044921. PubMed ID: 34225490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
    Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
    J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults.
    Liu Z; Pang C; Deng Y; Guo C; Li J; Li Y; Xin R; Li X; Xu C; Huang C; Lu H; Li J
    Vaccine; 2023 Jul; 41(34):4978-4985. PubMed ID: 37394372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    Forster AH; Witham K; Depelsenaire ACI; Veitch M; Wells JW; Wheatley A; Pryor M; Lickliter JD; Francis B; Rockman S; Bodle J; Treasure P; Hickling J; Fernando GJP
    PLoS Med; 2020 Mar; 17(3):e1003024. PubMed ID: 32181756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccine.
    Handabile C; Ohno M; Sekiya T; Nomura N; Kawakita T; Kawahara M; Endo M; Nishimura T; Okumura M; Toba S; Sasaki M; Orba Y; Chua BY; Rowntree LC; Nguyen THO; Shingai M; Sato A; Sawa H; Ogasawara K; Kedzierska K; Kida H
    Sci Rep; 2024 Feb; 14(1):4204. PubMed ID: 38378856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-induced neutralizing antibody responses to seasonal influenza virus H1N1 strains are not enhanced during subsequent pandemic H1N1 infection.
    Mooij P; Mortier D; Aartse A; Murad AB; Correia R; Roldão A; Alves PM; Fagrouch Z; Eggink D; Stockhofe N; Engelhardt OG; Verschoor EJ; van Gils MJ; Bogers WM; Carrondo MJT; Remarque EJ; Koopman G
    Front Immunol; 2023; 14():1256094. PubMed ID: 37691927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine.
    Sun Y; Bian C; Xu K; Hu W; Wang T; Cui J; Wu H; Ling Z; Ji Y; Lin G; Tian L; Zhou Y; Li B; Hu G; Yu N; An W; Pan R; Zhou P; Leng Q; Huang Z; Ma X; Sun B
    PLoS One; 2010 Dec; 5(12):e14270. PubMed ID: 21151563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study.
    Leroux-Roels I; Roman F; Forgus S; Maes C; De Boever F; Dramé M; Gillard P; van der Most R; Van Mechelen M; Hanon E; Leroux-Roels G
    Vaccine; 2010 Jan; 28(3):849-57. PubMed ID: 19835828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine.
    Nakayama M; Shichinohe S; Itoh Y; Ishigaki H; Kitano M; Arikata M; Pham VL; Ishida H; Kitagawa N; Okamatsu M; Sakoda Y; Ichikawa T; Tsuchiya H; Nakamura S; Le QM; Ito M; Kawaoka Y; Kida H; Ogasawara K
    PLoS One; 2013; 8(12):e82740. PubMed ID: 24376571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.